Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 10, 2019
Event: Regulation FD Disclosure regarding an Investor Day presentation held on June 10, 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure notice for an investor presentation (Exhibit 99.1) rather than a financial statement.
Material Changes
No material financial changes or comparative period data are disclosed within the text of this filing. The document solely references the furnishing of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company furnished an investor presentation used at its Investor Day on June 10, 2019, which may be used in subsequent meetings with investors or analysts.
Legal Status: The information in this report and the attached exhibit is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation dated June 10, 2019) for specific financial guidance and strategic outlook.
- Verify that the presentation content has not been superseded by subsequent filings or announcements.
- Note that the information provided is not legally "filed" for liability purposes under Section 18 of the Exchange Act.